Achilles Therapeutics plc Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Achilles Therapeutics plc quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Achilles Therapeutics plc Depreciation for the quarter ending June 30, 2024 was $1.2M, a 7.69% decline year-over-year.
  • Achilles Therapeutics plc annual Depreciation for 2023 was $4.7M, a 27% increase from 2022.
  • Achilles Therapeutics plc annual Depreciation for 2022 was $3.7M, a 12.1% increase from 2021.
  • Achilles Therapeutics plc annual Depreciation for 2021 was $3.3M, a 313% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.7M +$1M +27% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-04
2022 $3.7M +$400K +12.1% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-04
2021 $3.3M +$2.5M +313% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-04
2020 $800K +$500K +167% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 $300K Jan 1, 2019 Dec 31, 2019 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.